Thermo Fisher Scientific Return on Tangible Equity 2012-2026 | TMO
Current and historical return on tangible equity values for Thermo Fisher Scientific (TMO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Thermo Fisher Scientific Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $6.57B | $-12.68B | -51.81% |
| 2025-06-30 | $6.58B | $-12.56B | -52.42% |
| 2025-03-31 | $6.51B | $-12.56B | -51.85% |
| 2024-12-31 | $6.34B | $-13.05B | -48.56% |
| 2024-09-30 | $6.14B | $-13.58B | -45.19% |
| 2024-06-30 | $6.22B | $-13.91B | -44.74% |
| 2024-03-31 | $6.03B | $-15.15B | -39.84% |
| 2023-12-31 | $6.00B | $-16.25B | -36.89% |
| 2023-09-30 | $5.94B | $-16.41B | -36.20% |
| 2023-06-30 | $5.72B | $-16.25B | -35.20% |
| 2023-03-31 | $6.02B | $-16.35B | -36.85% |
| 2022-12-31 | $6.95B | $-16.67B | -41.70% |
| 2022-09-30 | $7.03B | $-18.31B | -38.40% |
| 2022-06-30 | $7.44B | $-14.67B | -50.71% |
| 2022-03-31 | $7.60B | $-10.96B | -69.39% |
| 2021-12-31 | $7.73B | $-7.09B | -109.02% |
| 2021-09-30 | $8.57B | $-2.84B | -301.29% |
| 2021-06-30 | $8.60B | $-4.52B | -190.25% |
| 2021-03-31 | $7.92B | $-6.16B | -128.70% |
| 2020-12-31 | $6.38B | $-7.66B | -83.25% |
| 2020-09-30 | $4.88B | $-9.12B | -53.51% |
| 2020-06-30 | $3.71B | $-10.06B | -36.85% |
| 2020-03-31 | $3.67B | $-10.78B | -34.03% |
| 2019-12-31 | $3.70B | $-11.14B | -33.18% |
| 2019-09-30 | $3.59B | $-11.81B | -30.41% |
| 2019-06-30 | $3.54B | $-12.53B | -28.25% |
| 2019-03-31 | $3.17B | $-13.15B | -24.14% |
| 2018-12-31 | $2.94B | $-14.05B | -20.91% |
| 2018-09-30 | $2.57B | $-15.01B | -17.11% |
| 2018-06-30 | $2.39B | $-16.00B | -14.96% |
| 2018-03-31 | $2.25B | $-15.67B | -14.38% |
| 2017-12-31 | $2.23B | $-15.16B | -14.68% |
| 2017-09-30 | $2.33B | $-14.46B | -16.10% |
| 2017-06-30 | $2.27B | $-13.71B | -16.54% |
| 2017-03-31 | $2.17B | $-13.23B | -16.42% |
| 2016-12-31 | $2.02B | $-12.82B | -15.78% |
| 2016-09-30 | $2.00B | $-11.94B | -16.71% |
| 2016-06-30 | $2.00B | $-11.06B | -18.07% |
| 2016-03-31 | $1.99B | $-11.15B | -17.86% |
| 2015-12-31 | $1.98B | $-11.28B | -17.52% |
| 2015-09-30 | $1.97B | $-11.82B | -16.70% |
| 2015-06-30 | $1.97B | $-12.40B | -15.89% |
| 2015-03-31 | $1.74B | $-13.12B | -13.24% |
| 2014-12-31 | $1.90B | $-13.78B | -13.75% |
| 2014-09-30 | $1.64B | $-11.36B | -14.40% |
| 2014-06-30 | $1.48B | $-8.88B | -16.70% |
| 2014-03-31 | $1.48B | $-6.25B | -23.66% |
| 2013-12-31 | $1.27B | $-3.59B | -35.49% |
| 2013-09-30 | $1.31B | $-4.11B | -31.79% |
| 2013-06-30 | $1.28B | $-4.56B | -28.03% |
| 2013-03-31 | $1.24B | $-4.70B | -26.31% |
| 2012-12-31 | $1.18B | $-4.73B | -24.89% |
| 2012-09-30 | $1.09B | $-4.71B | -23.13% |
| 2012-06-30 | $1.07B | $-4.65B | -22.90% |
| 2012-03-31 | $1.35B | $-3.88B | -34.92% |
| 2011-12-31 | $1.33B | $-2.65B | -50.08% |
| 2011-09-30 | $1.34B | $-1.35B | -98.80% |
| 2011-06-30 | $1.34B | $-0.16B | -862.38% |
| 2011-03-31 | $1.06B | $0.23B | 454.74% |
| 2010-12-31 | $1.04B | $0.18B | 590.58% |
| 2010-09-30 | $1.01B | $0.09B | 1123.33% |
| 2010-06-30 | $0.96B | $0.23B | 426.58% |
| 2010-03-31 | $0.93B | $0.19B | 492.35% |
| 2009-12-31 | $0.85B | $0.18B | 469.61% |
| 2009-09-30 | $0.86B | $0.11B | 787.24% |
| 2009-06-30 | $0.86B | $-0.09B | -962.01% |
| 2009-03-31 | $0.90B | $-0.25B | -358.57% |
| 2008-12-31 | $0.98B | $-0.53B | -184.38% |
| 2008-09-30 | $0.92B | $-0.83B | -110.34% |
| 2008-06-30 | $0.92B | $-1.05B | -87.55% |
| 2008-03-31 | $0.84B | $-1.21B | -69.38% |
| 2007-12-31 | $0.75B | $-1.37B | -54.54% |
| 2007-09-30 | $0.55B | $-1.56B | -35.09% |
| 2007-06-30 | $0.38B | $-1.16B | -32.53% |
| 2007-03-31 | $0.26B | $-0.77B | -34.04% |
| 2006-12-31 | $0.17B | $-0.22B | -75.96% |
| 2006-09-30 | $0.20B | $0.40B | 49.66% |
| 2006-06-30 | $0.21B | $0.39B | 53.62% |
| 2006-03-31 | $0.22B | $0.37B | 60.01% |
| 2005-12-31 | $0.22B | $0.50B | 45.05% |
| 2005-09-30 | $0.29B | $0.65B | 44.34% |
| 2005-06-30 | $0.34B | $0.76B | 44.50% |
| 2005-03-31 | $0.37B | $0.91B | 40.67% |
| 2004-12-31 | $0.36B | $0.85B | 42.60% |
| 2004-09-30 | $0.30B | $0.82B | 36.95% |
| 2004-06-30 | $0.25B | $0.83B | 29.71% |
| 2004-03-31 | $0.21B | $0.80B | 25.90% |
| 2003-12-31 | $0.20B | $0.77B | 26.05% |
| 2003-09-30 | $0.23B | $0.70B | 32.03% |
| 2003-06-30 | $0.22B | $0.64B | 33.57% |
| 2003-03-31 | $0.23B | $0.61B | 38.09% |
| 2002-12-31 | $0.31B | $0.60B | 51.30% |
| 2002-09-30 | $0.22B | $0.59B | 36.56% |
| 2002-06-30 | $0.20B | $0.68B | 29.73% |
| 2002-03-31 | $0.16B | $0.81B | 19.68% |
| 2001-12-31 | $0.00B | $0.92B | -0.11% |
| 2001-09-30 | $-0.07B | $1.07B | -6.53% |
| 2001-06-30 | $-0.08B | $1.13B | -7.43% |
| 2001-03-31 | $-0.09B | $1.08B | -7.89% |
| 2000-12-31 | $-0.04B | $1.00B | -3.59% |
| 2000-09-30 | $0.04B | $0.91B | 3.96% |
| 2000-06-30 | $0.06B | $0.64B | 8.98% |
| 2000-03-31 | $-0.20B | $0.42B | -48.21% |
| 1999-12-31 | $-0.18B | $0.26B | -68.59% |
| 1999-09-30 | $-0.14B | $0.15B | -94.00% |
| 1999-06-30 | $-0.15B | $0.22B | -69.80% |
| 1999-03-31 | $0.15B | $0.35B | 41.55% |
| 1998-12-31 | $0.18B | $0.39B | 47.00% |
| 1998-09-30 | $0.21B | $0.38B | 56.20% |
| 1998-06-30 | $0.26B | $0.36B | 71.62% |
| 1998-03-31 | $0.25B | $0.31B | 81.36% |
| 1997-12-31 | $0.24B | $0.33B | 71.88% |
| 1997-09-30 | $0.22B | $0.44B | 50.56% |
| 1997-06-30 | $0.21B | $0.53B | 40.06% |
| 1997-03-31 | $0.20B | $0.59B | 34.52% |
| 1996-12-31 | $0.19B | $0.59B | 32.27% |
| 1996-09-30 | $0.18B | $0.52B | 33.57% |
| 1996-06-30 | $0.16B | $0.50B | 32.95% |
| 1996-03-31 | $0.15B | $0.48B | 31.79% |
| 1995-12-31 | $0.14B | $0.48B | 29.39% |
| 1995-09-30 | $0.13B | $0.47B | 27.97% |
| 1995-06-30 | $0.12B | $0.44B | 27.29% |
| 1995-03-31 | $0.11B | $0.40B | 27.66% |
| 1994-12-31 | $0.10B | $0.37B | 28.13% |
| 1994-09-30 | $0.10B | $0.36B | 27.34% |
| 1994-06-30 | $0.09B | $0.42B | 21.71% |
| 1994-03-31 | $0.09B | $0.43B | 19.96% |
| 1993-12-31 | $0.08B | $0.43B | 17.97% |
| 1993-09-30 | $0.07B | $0.42B | 17.30% |
| 1993-06-30 | $0.07B | $0.35B | 19.48% |
| 1993-03-31 | $0.06B | $0.38B | 16.88% |
| 1992-12-31 | $0.06B | $0.42B | 14.95% |
| 1992-09-30 | $0.06B | $0.43B | 13.39% |
| 1992-06-30 | $0.06B | $0.44B | 12.61% |
| 1992-03-31 | $0.05B | $0.39B | 13.20% |
| 1991-12-31 | $0.05B | $0.34B | 14.03% |
| 1991-09-30 | $0.04B | $0.28B | 15.18% |
| 1991-06-30 | $0.04B | $0.24B | 16.47% |
| 1991-03-31 | $0.04B | $0.22B | 17.05% |
| 1990-12-31 | $0.04B | $0.21B | 16.43% |
| 1990-09-30 | $0.03B | $0.21B | 16.06% |
| 1990-06-30 | $0.03B | $0.21B | 14.96% |
| 1990-03-31 | $0.03B | $0.20B | 14.46% |
| 1989-12-31 | $0.03B | $0.19B | 14.97% |
| 1989-09-30 | $0.03B | $0.16B | 16.67% |
| 1989-06-30 | $0.03B | $0.15B | 16.72% |
| 1989-03-31 | $0.02B | $0.14B | 16.99% |
| 1988-12-31 | $0.02B | $0.13B | 17.23% |
| 1988-09-30 | $0.02B | $0.14B | 13.67% |
| 1988-06-30 | $0.02B | $0.14B | 13.50% |
| 1988-03-31 | $0.02B | $0.14B | 12.97% |
| 1987-12-31 | $0.02B | $0.14B | 13.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $184.365B | $44.556B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |